Galectin Therapeutics Reports 2018 Third Quarter Financial Results and Provides Business Update
13 nov. 2018 08h00 HE
|
Galectin Therapeutics Inc.
NORCROSS, Ga., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin proteins, today reported financial results for...